Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.
Sign up today and learn more about Apnimed Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Apnimed Stock
Founder, CEO & Board Chair
Lawrence G. Miller
Co-Founder and Medical Director
Luigi Taranto Montemurro
M.D & Senior Vice President of Clinical Development
Chief Financial Officer
SVP, Medical Affairs
Chief Commercial Officer